DA Davidson Adjusts Roblox Price Target Lower Amid Market Review USIndia Strategic Alliance Could Unlock Western Hemisphere Cooperation Says Rubio Roivant Shares Surge as Company Reports Swing to Profitability SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Technology AI Acceleration in Brain Condition Drug Discovery Draws Sector Interest Crude Oil Prices Stay Volatile Amid Middle East Tensions Julius Baer Points to Possible ShortLived Crisis Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD Ingles Markets Q1 2026 Earnings EPS of 128 Supports Stock Gain Amid Limited Disclosure MWA Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Expectations RB Global Inc RBA Q1 2026 Earnings EPS Slightly Beats Estimates Stock Rises on Positive Momentum MFG Q1 2026 Earnings Strong Earnings Beat Driven by Core Business Momentum MTNB Q4 2024 Earnings Narrowed Loss Surpasses Expectations Pipeline Momentum Continues Phio Pharmaceuticals PHIO Edges Higher Testing Key Resistance at 117 Herc Holdings HRI Slips Slightly Support and Resistance Levels in Focus Celanese Corporation CE Holds Near Support Amid Broader Market Pressure Actelis Networks Surges 449 as ASNS Holds at Key 009 Floor Vera Therapeutics VERA Edges Higher Testing Resistance Amid Steady Volume Jim Cramers Take on Home Depot Housing Market Trends and Interest Rates May Shape HD Stock Performance Workday Q1 2026 Earnings EPS Beat Propels Stock Higher Amid Solid Execution Sow Good Inc SOWG Holds Steady at 176 as Key Support and Resistance Levels Narrow BK Q1 2026 Earnings EPS Surpasses Estimates by 1326 BIPC Q1 2026 Earnings Significant EPS Miss Raises Concerns PFE Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Focus TAP Q1 2026 Earnings Stellar EPS Beat of 67 Surprises Analysts MSC Income Fund Inc MSIF Q1 2026 Earnings EPS Slightly Misses Estimates as Fund Advances KLXE Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Shares SION Q1 2026 Earnings EPS Misses Consensus as PreRevenue Biotech Advances Pipeline Stock Edges Higher